Notice of Interest Rate on Overdue Debts, 44124 [2013-17683]
Download as PDF
<![CDATA[
44124
Federal Register / Vol. 78, No. 141 / Tuesday, July 23, 2013 / Notices
are subject to delays due to heightened
security precautions. Thus, comments
instead should be sent by facsimile to
(202) 395–5167.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
David C. Shonka,
Principal Deputy General Counsel.
[Docket No. FDA–2013–N–0823]
Agency Information Collection
Activities: Proposed Collection;
Comment Request; Format and
Content Requirements for Over-theCounter Drug Product Labeling
[FR Doc. 2013–17560 Filed 7–22–13; 8:45 am]
BILLING CODE 6750–01–P
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ACTION:
Section 30.18 of the Department of
Health and Human Services’ claims
collection regulations (45 CFR Part 30)
provides that the Secretary shall charge
an annual rate of interest, which is
determined and fixed by the Secretary
of the Treasury after considering private
consumer rates of interest on the date
that the Department of Health and
Human Services becomes entitled to
recovery. The rate cannot be lower than
the Department of Treasury’s current
value of funds rate or the applicable rate
determined from the ‘‘Schedule of
Certified Interest Rates with Range of
Maturities’’ unless the Secretary waives
interest in whole or part, or a different
rate is prescribed by statute, contract, or
repayment agreement. The Secretary of
the Treasury may revise this rate
quarterly. The Department of Health and
Human Services publishes this rate in
the Federal Register.
The current rate of 103⁄8% as fixed by
the Secretary of the Treasury, is certified
for the quarter ended June 30, 2013.
This rate is based on the Interest Rates
for Specific Legislation, ‘‘National
Health Services Corps Scholarship
Program (42 U.S.C. 254o(b)) and
‘‘National Research Service Award
Program (42 U.S.C. 288(c)(4)(B)).’’ This
interest rate will be applied to overdue
debt until the Department of Health and
Human Services publishes a revision.
Dated: July 12, 2013.
Margie Yanchuk,
Director, Associate Deputy Assistant
Secretary.
ehiers on DSK2VPTVN1PROD with NOTICES
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the standardized format and content
requirements for the labeling of overthe-counter (OTC) drug products.
DATES: Submit either electronic or
written comments on the collection of
information by September 23, 2013.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT: Ila
S. Mizrachi, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
7726, Ila.Mizrachi@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
SUMMARY:
Notice of Interest Rate on Overdue
Debts
[FR Doc. 2013–17683 Filed 7–22–13; 8:45 am]
BILLING CODE 4150–04–P
15:40 Jul 22, 2013
Food and Drug Administration,
HHS.
Office of the Secretary
VerDate Mar<15>2010
Food and Drug Administration
Jkt 229001
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; (4) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques, when appropriate, and other
forms of information technology.
Format and Content Requirements for
OTC Drug Product Labeling—(OMB
Control Number 0910–0340)—Extension
In the Federal Register of March 17,
1999 (64 FR 13254) (the 1999 labeling
final rule), we amended our regulations
governing requirements for human drug
products to establish standardized
format and content requirements for the
labeling of all marketed OTC drug
products in part 201 (21 CFR Part 201).
The regulations in part 201 require OTC
drug product labeling to include
uniform headings and subheadings,
presented in a standardized order, with
minimum standards for type size and
other graphical features. Specifically,
the 1999 labeling final rule added new
§ 201.66 to part 201. Section 201.66 sets
content and format requirements for the
Drug Facts portion of labels on OTC
drug products.
On June 20, 2000 (65 FR 38191), we
published a Federal Register final rule
that required all OTC drug products
marketed under the OTC monograph
system to comply with the labeling
requirements in § 201.66 by May 16,
2005, or sooner (65 FR 38191 at 38193).
Currently marketed OTC drug products
are already required to be in compliance
with these labeling requirements, and
thus will incur no further burden to
comply with Drug Facts labeling
requirements in § 201.66. Modifications
of labeling already required to be in
Drug Facts format are usual and
customary as part of routine redesign
practice, and thus do not create
E:\FR\FM\23JYN1.SGM
23JYN1
]]>Agencies
[Federal Register Volume 78, Number 141 (Tuesday, July 23, 2013)]
[Notices]
[Page 44124]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-17683]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Notice of Interest Rate on Overdue Debts
Section 30.18 of the Department of Health and Human Services'
claims collection regulations (45 CFR Part 30) provides that the
Secretary shall charge an annual rate of interest, which is determined
and fixed by the Secretary of the Treasury after considering private
consumer rates of interest on the date that the Department of Health
and Human Services becomes entitled to recovery. The rate cannot be
lower than the Department of Treasury's current value of funds rate or
the applicable rate determined from the ``Schedule of Certified
Interest Rates with Range of Maturities'' unless the Secretary waives
interest in whole or part, or a different rate is prescribed by
statute, contract, or repayment agreement. The Secretary of the
Treasury may revise this rate quarterly. The Department of Health and
Human Services publishes this rate in the Federal Register.
The current rate of 10\3/8\% as fixed by the Secretary of the
Treasury, is certified for the quarter ended June 30, 2013. This rate
is based on the Interest Rates for Specific Legislation, ``National
Health Services Corps Scholarship Program (42 U.S.C. 254o(b)) and
``National Research Service Award Program (42 U.S.C. 288(c)(4)(B)).''
This interest rate will be applied to overdue debt until the Department
of Health and Human Services publishes a revision.
Dated: July 12, 2013.
Margie Yanchuk,
Director, Associate Deputy Assistant Secretary.
[FR Doc. 2013-17683 Filed 7-22-13; 8:45 am]
BILLING CODE 4150-04-P
